Affinity-free enrichment and mass spectrometry analysis of the ovarian cancer biomarker CA125 (MUC16) from patient-derived ascites
Keyword(s):
Developing a mass spectrometry-based assay for the ovarian cancer biomarker CA125 (MUC16) is a desirable goal, because it may enable detection of proteoforms that are analytically silent in the current immunoassay.
2017 ◽
Vol 16
(6)
◽
pp. 998-1008
◽
Keyword(s):
2006 ◽
2016 ◽
Vol 18
(4)
◽
pp. 365-369
◽
2013 ◽
Vol 30
(7)
◽
pp. 690-695
◽
2018 ◽
Vol 9
(4)
◽
1985 ◽
Vol 323
(1)
◽
pp. 135-141
◽